Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.26% | -57.12% | 7.53% | -248.48% | 54.79% |
| Total Depreciation and Amortization | 734.48% | 8.77% | -65.75% | 225.76% | -13.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 251.83% | 465.03% | 46.67% | 1,542.24% | -95.99% |
| Change in Net Operating Assets | -43.07% | -12.30% | 17.30% | -5.41% | 19.24% |
| Cash from Operations | -35.12% | -21.91% | 12.29% | -41.56% | 13.25% |
| Capital Expenditure | -652.63% | -- | 61.90% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -119.93% | -- | 1,809.52% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -861.54% | -- |
| Issuance of Common Stock | 63.93% | 877.76% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.93% | 939.57% | -- | 19,701.92% | 4,687.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.88% | 498.41% | 143.44% | 335.35% | 173.89% |